Fasudil and DETA NONOate, Loaded in a Peptide-Modified Liposomal Carrier, Slow PAH Progression upon Pulmonary Delivery.

about

Fasudil and DETA NONOate, Loaded in a Peptide-Modified Liposomal Carrier, Slow PAH Progression upon Pulmonary Delivery.

Item

http://www.wikidata.org/entity/Q51741338

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Fasudil and DETA NONOate, Load ...... ssion upon Pulmonary Delivery.

@en

Fasudil and DETA NONOate, Load ...... ssion upon Pulmonary Delivery.

@nl

type

Item

label

Fasudil and DETA NONOate, Load ...... ssion upon Pulmonary Delivery.

@en

Fasudil and DETA NONOate, Load ...... ssion upon Pulmonary Delivery.

@nl

prefLabel

Fasudil and DETA NONOate, Load ...... ssion upon Pulmonary Delivery.

@en

Fasudil and DETA NONOate, Load ...... ssion upon Pulmonary Delivery.

@nl

P1476

Fasudil and DETA NONOate, Load ...... ession upon Pulmonary Delivery

@en

P2093

Ali Keshavarz

http://www.w3.org/2001/XMLSchema#string

Jahidur Rashid

http://www.w3.org/2001/XMLSchema#string

Kamrun Nahar

http://www.w3.org/2001/XMLSchema#string

Snehal Raut

http://www.w3.org/2001/XMLSchema#string

P2860

Biochemistry and genetics of von Willebrand factor

Management of pulmonary arterial hypertension

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

Inhaled PLGA particles of prostaglandin E₁ ameliorate symptoms and progression of pulmonary hypertension at a reduced dosing frequency.

Combination therapy in pulmonary arterial hypertension: a meta-analysis.

Target-seeking antifibrotic compound enhances wound healing and suppresses scar formation in mice.

Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells

Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms.

Peptide-directed highly selective targeting of pulmonary arterial hypertension.

Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension.

P304

1755-1765

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACS.MOLPHARMACEUT.7B01003

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fakhrul Ahsan

P577

2018-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29528655

http://www.w3.org/2001/XMLSchema#string

P932

5938133

http://www.w3.org/2001/XMLSchema#string